NurExone Announces Voting Results of Annual General and Special Meeting of Shareholders and Provides Corporate Update
Shareholders grant the Board discretionary authority to implement a share consolidation of up to 30:1TORONTO and HAIFA, Israel, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. TSXV:NRX OTCQB:NRXBF FSE:J90 (“NurExone” or the “Company”), a biotechnology company developing exosome-based rege…